The Directorate General of Health Services (DGHS) has issued a nationwide directive strictly prohibiting the reuse of medical devices and disposable surgical items. In a formal communication dated October 16, the DGHS mandated that all healthcare institutions across India, spanning both public and private sectors, must adhere to manufacturer instructions for single-use products. The order emphasizes that any practice involving the sterilization or reprocessing of items intended for one-time use is now prohibited.
This government intervention follows reports that certain private and corporate hospitals were bypassing safety protocols by sterilizing and reusing disposable devices. The DGHS noted that this practice was particularly prevalent in critical medical specialties, including cardiology, nephrology, oncology, neurosurgery, and cardiothoracic and vascular surgery (CTVS). Beyond safety concerns, the report highlighted instances where hospitals continued to charge patients or claim government reimbursements for these devices as if they were new, despite having reused them.
Dr. Loveneesh G. Krishna, head of the DGHS, stated that the Health Ministry views the issue with gravity. The directive reminds healthcare providers that violating these standards may contravene several existing regulatory frameworks, including the Drugs and Cosmetics Act of 1940, the Medical Devices Rules of 2017, and the Clinical Establishments Act of 2010. Furthermore, the practice is seen as a breach of standard biomedical waste management provisions and infection control protocols.
The risk profile associated with the reuse of such devices is significant. Medical professionals have warned that reprocessing items not designed for repeated sterilization can lead to device malfunction, reduced performance, and serious health complications. Dr. Pragya Shukla, head of clinical oncology at the Delhi Cancer Institute, explained that repeatedly autoclaving or reheating items intended for single use can degrade the material quality. Such degradation, she noted, poses a heightened risk of cross-infection, potentially exposing patients to sepsis and other complications transmitted through blood or bodily fluids.
To ensure widespread compliance, the DGHS has instructed state and union territory health officials, as well as the Drug Controller General of India, to exercise strict vigilance. The directive explicitly states that authorities may conduct inspections and monitor healthcare establishments to enforce the ban. Facilities found to be non-compliant will face action in accordance with applicable laws.
While the medical community has largely welcomed the safety-focused measure, some experts have pointed to the potential financial implications. Dr. Sudhir Kumar, a neurologist at Apollo Hospitals, Hyderabad, observed that while the reuse of devices is difficult to justify from a clinical or regulatory standpoint, it was often driven by cost pressures within the healthcare system. He acknowledged that the industry will need to navigate the resulting impact on patient costs and overall healthcare expenditure as institutions shift toward strictly adhering to original equipment manufacturer guidelines.
This latest mandate follows similar regulatory efforts, including a previous order issued by the Central Government Health Scheme (CGHS) in 2016 regarding the same practice. The DGHS has now requested the wide dissemination of this current order to ensure that all healthcare organizations are fully aware of their obligations to patient safety and regulatory compliance moving forward.
Comments